{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:03Z","timestamp":1793105703464,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guidance Project of Jiangsu Provincial Health Commission","award":["Z2023074"],"award-info":[{"award-number":["Z2023074"]}]},{"name":"Suzhou Clinical Medical Center for Mood Disorders","award":["Szlcyxzx202109"],"award-info":[{"award-number":["Szlcyxzx202109"]}]},{"name":"Suzhou Key Laboratory","award":["SZS2024016"],"award-info":[{"award-number":["SZS2024016"]}]},{"name":"Suzhou Multicenter Clinical Research Project on Major Diseases","award":["DZXYJ202413"],"award-info":[{"award-number":["DZXYJ202413"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07668-5","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T17:46:47Z","timestamp":1764438407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Abnormal serum IL-10 and IL-19 levels in childhood- and adolescent-onset schizophrenia: associations with negative symptoms and language function"],"prefix":"10.1186","volume":"26","author":[{"given":"Haidong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingshu","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"12","key":"7668_CR1","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, Tuominen L, Darg\u00e9l A, Carvalho AF, Fornaro M, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol Psychiatry. 2023;28(12):5319\u201327.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"7668_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD","year":"2022","unstructured":"GBD. Global, regional, and National burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9(2):137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"7668_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","volume":"264","author":"R Tandon","year":"2024","unstructured":"Tandon R, Nasrallah H, Akbarian S, Carpenter WT Jr., DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, et al. The schizophrenia syndrome, circa 2024: what we know and how that informs its nature. Schizophr Res. 2024;264:1\u201328.","journal-title":"Schizophr Res"},{"issue":"1","key":"7668_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27(1):281\u201395.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"7668_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","volume":"79","author":"JA Williams","year":"2022","unstructured":"Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL, Palmer E, Karwath A, Barsky A, Gkoutos GV, et al. Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: A Mendelian randomization study. JAMA Psychiatry. 2022;79(5):498\u2013507.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"7668_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","volume":"10","author":"S Halstead","year":"2023","unstructured":"Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Shih-Jung Liu Z, Walder K, Warren N. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260\u201371.","journal-title":"Lancet Psychiatry"},{"key":"7668_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pnpbp.2013.12.006","volume":"50","author":"S Okazaki","year":"2014","unstructured":"Okazaki S, Watanabe Y, Hishimoto A, Sasada T, Mouri K, Shiroiwa K, Eguchi N, Ratta-Apha W, Otsuka I, Nunokawa A, et al. Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:151\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7668_CR8","doi-asserted-by":"crossref","unstructured":"Abhiraman GC, Householder KD, Rodriguez GE, Glassman CR, Saxton RA, Breuer CB, Wilson SC, Su L, Yen M, Hsu C, et al. Redirecting immune signaling with cytokine adaptors. Nat Commun. 2025;16(1).","DOI":"10.1038\/s41467-025-57681-1"},{"key":"7668_CR9","doi-asserted-by":"crossref","unstructured":"Peluzzo AM, Autieri MV. Challenging the paradigm: anti-inflammatory interleukins and angiogenesis. Cells. 2022;11(3).","DOI":"10.3390\/cells11030587"},{"key":"7668_CR10","doi-asserted-by":"crossref","unstructured":"Malashenkova IK, Ushakov VL, Zakharova NV, Krynskiy SA, Ogurtsov DP, Hailov NA, Chekulaeva EI, Ratushnyy AY, Kartashov SI, Kostyuk GP, et al. Neuro-Immune aspects of schizophrenia with severe negative symptoms: new diagnostic markers of disease phenotype. Sovremennye Tehnologii V Med. 2021;13(6).","DOI":"10.17691\/stm2021.13.6.03"},{"key":"7668_CR11","doi-asserted-by":"crossref","unstructured":"Binic I, Petrovic J, Zikic O, Golubovic ST, Djordjevic V, Stevanovic M, Krtinic D, Andjelkovic Apostolovic M. Clinical relevance of peripheral interleukins in drug-naive first-episode psychosis: symptom-specific associations from the PANSS dimensions. Brain Sci. 2025;15(9).","DOI":"10.3390\/brainsci15090932"},{"issue":"5","key":"7668_CR12","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28(5):1902\u201318.","journal-title":"Mol Psychiatry"},{"key":"7668_CR13","doi-asserted-by":"crossref","unstructured":"Zhang T, Wei Y, Tang X, Xu L, Cui H, Hu Y, Liu H, Wang Z, Chen T, Li C, et al. Cognitive impairment in adolescent and adult-onset psychosis: a comparative study. Child Adolesc Psychiatry Mental Health. 2024;18(1).","DOI":"10.1186\/s13034-024-00815-y"},{"key":"7668_CR14","doi-asserted-by":"crossref","unstructured":"Guo T, Chen L, Luan L, Yang M, Zhang X, Yang H. Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits. BMC Psychiatry. 2024;24(1).","DOI":"10.1186\/s12888-024-06288-9"},{"issue":"1","key":"7668_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1017\/S1092852921000857","volume":"28","author":"MH Chen","year":"2023","unstructured":"Chen MH, Hsu JW, Huang KL, Tsai SJ, Tu PC, Bai YM. Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder. CNS Spectr. 2023;28(1):70\u20137.","journal-title":"CNS Spectr"},{"issue":"1","key":"7668_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12888-024-06163-7","volume":"24","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhu W, Bu Y, Li J, Hao Y, Bi Y. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-\u03b1 levels in drug-naive individuals with first-episode schizophrenia. BMC Psychiatry. 2024;24(1):703.","journal-title":"BMC Psychiatry"},{"key":"7668_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/NDT.S396168","volume":"19","author":"C Miljevic","year":"2023","unstructured":"Miljevic C, Munjiza-Jovanovic A, Jovanovic T. Impact of childhood Adversity, as early life Distress, on cytokine alterations in schizophrenia. Neuropsychiatr Dis Treat. 2023;19:579\u201386.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"7668_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00787-022-01957-0","volume":"32","author":"P Camprodon-Boadas","year":"2022","unstructured":"Camprodon-Boadas P, Rosa-Justicia M, Sugranyes G, Moreno D, Baeza I, Ilzarbe D, Mart\u00ednez D\u00edaz-Caneja C, Ayora M, Merchan J, Mart\u00edn N, et al. Cognitive reserve and its correlates in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder. Eur Child Adolesc Psychiatry. 2022;32(8):1463\u201373.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"7668_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"key":"7668_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.euroneuro.2025.03.011","volume":"95","author":"V Llorca-Bof\u00ed","year":"2025","unstructured":"Llorca-Bof\u00ed V, Garriga M, Mezquida G, Garcia-Rizo C, Vieta E, D\u00edaz-Caneja CM, Bernardo M, Madero S, Pina-Camacho L, Cuesta MJ, et al. Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort. Eur Neuropsychopharmacol. 2025;95:9\u201313.","journal-title":"Eur Neuropsychopharmacol"},{"key":"7668_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jad.2023.06.015","volume":"338","author":"X Liang","year":"2023","unstructured":"Liang X, Qiao D, Ren T, Wen Y, Xu Y, Ma L, Li Q, Li G, Liu Z. Neural association between cognitive function and anhedonia in adolescents with melancholic major depressive disorder: A fNIRS study. J Affect Disord. 2023;338:305\u201311.","journal-title":"J Affect Disord"},{"key":"7668_CR22","doi-asserted-by":"crossref","unstructured":"Shi S, Zhang S, Kong L. Effects of treatment with probiotics on cognitive function and regulatory role of cortisol and IL-1\u03b2 in adolescent patients with major depressive disorder. Life. 2023;13(9).","DOI":"10.3390\/life13091829"},{"key":"7668_CR23","doi-asserted-by":"crossref","unstructured":"Yang H, Tian Q, Luan L, Yang M, Li C, Zhang X. NGF-\u03b2 and BDNF levels are altered in male patients with chronic schizophrenia: effects on clinical symptoms. BMC Psychiatry. 2025;25(1).","DOI":"10.1186\/s12888-025-06685-8"},{"key":"7668_CR24","doi-asserted-by":"crossref","unstructured":"Guerrin CGJ, Prasad K, Vazquez-Matias DA, Zheng J, Franquesa-Mullerat M, Barazzuol L, Doorduin J, de Vries EFJ. Prenatal infection and adolescent social adversity affect microglia, synaptic density, and behavior in male rats. Neurobiol Stress. 2023;27.","DOI":"10.1016\/j.ynstr.2023.100580"},{"key":"7668_CR25","doi-asserted-by":"crossref","unstructured":"Azuma Y-T, Fujita T, Izawa T, Hirota K, Nishiyama K, Ikegami A, Aoyama T, Ike M, Ushikai Y, Kuwamura M, et al. IL-19 contributes to the development of nonalcoholic steatohepatitis by altering lipid metabolism. Cells. 2021;10(12).","DOI":"10.3390\/cells10123513"},{"key":"7668_CR26","doi-asserted-by":"crossref","unstructured":"Li X, Huang J, Chen X, Lai X, Huang Z, Li Y, Li S, Chang L, Zhang G. IL-19 induced by IL\u201013\/IL\u201017A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP\u20109 expression via ERK\/NF\u2010\u03baB signaling pathway. Clinical and Translational Allergy. 2021;11(1).","DOI":"10.1002\/clt2.12003"},{"key":"7668_CR27","doi-asserted-by":"crossref","unstructured":"Della Bella C, Antico A, Panozzo MP, Capitani N, Benagiano M, Petrone L, Azzurri A, Pratesi S, D\u2019Elios S, Cianchi F, et al. Elevated IL-19 serum levels in patients with pernicious anemia and autoimmune gastritis. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.887256"},{"key":"7668_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jad.2023.12.012","volume":"347","author":"L Wen","year":"2024","unstructured":"Wen L, Yan C, Si T, Huang L, Nie Y, Shen H, Qu M, Zhang X. The predictive role of early inflammation and oxidative stress and the dynamics of cytokines networks in post-stroke depression. J Affect Disord. 2024;347:469\u201376.","journal-title":"J Affect Disord"},{"key":"7668_CR29","doi-asserted-by":"crossref","unstructured":"Lee GA, Hsu JB-K, Chang Y-W, Hsieh L-C, Li Y-T, Wu YC, Chu C-Y, Chiang Y-H, Guo W-Y, Wu C-C, et al. IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment. J Biomed Sci. 2025;32(1).","DOI":"10.1186\/s12929-025-01126-w"},{"issue":"1","key":"7668_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12991-025-00575-9","volume":"24","author":"V Baldini","year":"2025","unstructured":"Baldini V, Gnazzo M, Varallo G, Atti AR, De Ronchi D, Fiorillo A, Plazzi G. Inflammatory markers and suicidal behavior: A comprehensive review of emerging evidence. Ann Gen Psychiatry. 2025;24(1):36.","journal-title":"Ann Gen Psychiatry"},{"key":"7668_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","volume":"230","author":"D Enache","year":"2021","unstructured":"Enache D, Nikkheslat N, Fathalla D, Morgan BP, Lewis S, Drake R, Deakin B, Walters J, Lawrie SM, Egerton A, et al. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophr Res. 2021;230:1\u20138.","journal-title":"Schizophr Res"},{"issue":"8","key":"7668_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1089\/cap.2015.0220","volume":"26","author":"S Simsek","year":"2016","unstructured":"Simsek S, Yildirim V, Cim A, Kaya S. Serum IL-4 and IL-10 levels correlate with the symptoms of the Drug-Naive adolescents with first Episode, early onset schizophrenia. J Child Adolesc Psychopharmacol. 2016;26(8):721\u20136.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"7668_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7150\/ijms.38891","volume":"17","author":"JY Liu","year":"2020","unstructured":"Liu JY, Chen HY, Lin JJ, Lu MK, Tan HP, Jang FL, Lin SH. Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signs. Int J Med Sci. 2020;17(2):255\u201362.","journal-title":"Int J Med Sci"},{"key":"7668_CR34","doi-asserted-by":"crossref","unstructured":"Tang C, Zheng X, Zhong Y, Chen D, Zhu Y, Wang S, Xiong L, Zhu Z. The role of TREM1 in regulating microglial polarization in sevoflurane-induced perioperative neurocognitive disorders. J Neuroimmunol. 2023;379.","DOI":"10.1016\/j.jneuroim.2023.578070"},{"key":"7668_CR35","doi-asserted-by":"crossref","unstructured":"Jiang S, Wan Q, Wang X, Di L, Li X, Kang R, Li S, Huang L. LXA4 attenuates perioperative neurocognitive disorders by suppressing neuroinflammation and oxidative stress. Int Immunopharmacol. 2023;123.","DOI":"10.1016\/j.intimp.2023.110788"},{"key":"7668_CR36","doi-asserted-by":"publisher","first-page":"111166","DOI":"10.1016\/j.pnpbp.2024.111166","volume":"136","author":"TH Zhang","year":"2024","unstructured":"Zhang TH, Chen X, Wei YY, Tang XC, Xu LH, Cui HR, Liu HC, Wang ZX, Chen T, Li CB, et al. Associations between cytokine levels and cognitive function among individuals at clinical high risk for psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 2024;136:111166.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7668_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbi.2025.04.024","volume":"128","author":"SR Patlola","year":"2025","unstructured":"Patlola SR, Holleran L, Dauvermann MR, Rokita K, Laighneach A, Hallahan B, McManus R, Kenyon M, McDonald C, Morris DW, et al. Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients \u2013 A mediation analysis. Brain Behav Immun. 2025;128:529\u201339.","journal-title":"Brain Behav Immun"},{"key":"7668_CR38","doi-asserted-by":"crossref","unstructured":"Hatzimanolis A, Foteli S, Xenaki L-A, Selakovic M, Dimitrakopoulos S, Vlachos I, Kosteletos I, Soldatos R-F, Gazouli M, Chatzipanagiotou S et al. Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics. Schizophrenia. 2024;10(1).","DOI":"10.1038\/s41537-024-00483-z"},{"issue":"1","key":"7668_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13416","volume":"146","author":"C Dunleavy","year":"2022","unstructured":"Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand. 2022;146(1):6\u201320.","journal-title":"Acta Psychiatr Scand"},{"key":"7668_CR40","doi-asserted-by":"crossref","unstructured":"Sheng JA, Tobet SA. Maternal immune activation with toll-like receptor 7 agonist during mid\u2010gestation alters juvenile and adult developmental milestones and behavior. J Neuroendocrinol. 2024;36(8).","DOI":"10.1111\/jne.13417"},{"issue":"6","key":"7668_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/schbul\/sbn054","volume":"35","author":"CJ Carter","year":"2008","unstructured":"Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: Cytomegalovirus, Influenza, herpes simplex, Rubella, and Toxoplasma gondii. Schizophr Bull. 2008;35(6):1163\u201382.","journal-title":"Schizophr Bull"},{"key":"7668_CR42","doi-asserted-by":"publisher","first-page":"148667","DOI":"10.1016\/j.brainres.2023.148667","volume":"1822","author":"T Beatriz Gonz\u00e1lez-Castro","year":"2024","unstructured":"Beatriz Gonz\u00e1lez-Castro T, Alfonso Tovilla-Z\u00e1rate C, Esther Ju\u00e1rez-Rojop I, Hern\u00e1ndez-D\u00edaz Y, Lilia L\u00f3pez-Narv\u00e1ez M, Felicita Ortiz-Ojeda R. The association of cytokines genes (IL-6 and IL-10) with the susceptibility to schizophrenia: A systematic review and meta-analysis. Brain Res. 2024;1822:148667.","journal-title":"Brain Res"},{"key":"7668_CR43","doi-asserted-by":"crossref","unstructured":"Armita A, Guivarch J, Dor E, Laure G, Zeghari R, Gindt M, Th\u00fcmmler S, Askenazy F, Fernandez A. Neurocognitive dysfunctions in childhood-onset schizophrenia: a systematic review. Schizophrenia Research: Cognition. 2025;40.","DOI":"10.1016\/j.scog.2024.100342"},{"key":"7668_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajp.2019.05.031","volume":"43","author":"S Grover","year":"2019","unstructured":"Grover S, Sahoo S, Nehra R. A comparative study of childhood\/adolescent and adult onset schizophrenia: does the neurocognitive and psychosocial outcome differ? Asian J Psychiatry. 2019;43:160\u20139.","journal-title":"Asian J Psychiatry"},{"key":"7668_CR45","doi-asserted-by":"publisher","first-page":"115173","DOI":"10.1016\/j.psychres.2023.115173","volume":"323","author":"AA Tucci","year":"2023","unstructured":"Tucci AA, Schroeder A, No\u00ebl C, Shvetz C, Yee J, Howard AL, Keshavan MS, Guimond S. Social cognition in youth with a first-degree relative with schizophrenia: A systematic scoping review. Psychiatry Res. 2023;323:115173.","journal-title":"Psychiatry Res"},{"issue":"9","key":"7668_CR46","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00787-022-01977-w","volume":"32","author":"Y Sa\u011flam","year":"2022","unstructured":"Sa\u011flam Y, Ermi\u015f \u00c7, Tun\u00e7t\u00fcrk M, Turan S, Karaku\u015f OB, Alarslan S, Kara\u00e7etin G. Neurocognitive and social cognitive impairments in remission and symptomatic States of early-onset schizophrenia spectrum disorders. Eur Child Adolesc Psychiatry. 2022;32(9):1621\u201331.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"7668_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.biopsych.2022.03.004","volume":"92","author":"LJ Benoit","year":"2022","unstructured":"Benoit LJ, Canetta S, Kellendonk C. Thalamocortical development: A neurodevelopmental framework for schizophrenia. Biol Psychiatry. 2022;92(6):491\u2013500.","journal-title":"Biol Psychiatry"},{"key":"7668_CR48","doi-asserted-by":"crossref","unstructured":"Perica MI, Luna B. Impact of stress on excitatory and inhibitory markers of adolescent cognitive critical period plasticity. Neurosci Biobehavioral Reviews. 2023;153.","DOI":"10.1016\/j.neubiorev.2023.105378"},{"key":"7668_CR49","doi-asserted-by":"crossref","unstructured":"Felgel-Farnholz V, Hlusicka EB, Edemann-Callesen H, Garthe A, Winter C, Hadar R. Adolescent raloxifene treatment in females prevents cognitive deficits in a neurodevelopmental rodent model of schizophrenia. Behav Brain Res. 2023;441.","DOI":"10.1016\/j.bbr.2022.114276"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07668-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:21:18Z","timestamp":1767633678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7668"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07668-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that all human experimentation was conducted in accordance with the Declaration of Helsinki and that all procedures were carried out with the adequate understanding and written consent of the subjects. All experimental protocols were approved by the Ethics Committee of Lianyungang Fourth People\u2019s Hospital. Informed consent was obtained from all participants and\/or their legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Artificial intelligence (AI) tools were used only for minor language editing (e.g., grammar and style checks). All scientific content, interpretations, and conclusions were generated by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted techniques"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}